Home  »  Company News   »  Salarius Pharmaceuticals Inc. (SLRX) went up 8.86%...

Salarius Pharmaceuticals Inc. (SLRX) went up 8.86% yesterday: Is this the Most Sought-After Stock Today?

Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) started the day on November 08, 2021, with a price increase of 8.86% at $0.82. During the day, the stock rose to $0.835 and sunk to $0.76 before settling in for the price of $0.76 at the close. Taking a more long-term approach, SLRX posted a 52-week range of $0.64-$3.50.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


>> 7 Top Picks for the Post-Pandemic Economy << 

Meanwhile, its Annual Earning per share during the time was 60.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 76.60%. This publicly-traded company’s shares outstanding now amounts to $49.41 million, simultaneously with a float of $44.10 million. The organization now has a market capitalization sitting at $40.74 million. At the time of writing, stock’s 50-day Moving Average stood at $0.9672, while the 200-day Moving Average is $1.2129.

It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 9 workers. It has generated 581,478 per worker during the last fiscal year. Meanwhile, its income per employee was -816,917. The stock had 2.71 Receivables turnover and 0.27 Total Asset turnover. For the Profitability, stocks operating margin was -148.78 and Pretax Margin of -140.49.

Salarius Pharmaceuticals Inc. (SLRX) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Salarius Pharmaceuticals Inc.’s current insider ownership accounts for 1.51%, in contrast to 27.50% institutional ownership. According to the most recent insider trade that took place on Aug 17, this organization’s Chief Executive Officer bought 4,000 shares at the rate of 0.90, making the entire transaction reach 3,582 in total value, affecting insider ownership by 102,247. Preceding that transaction, on Aug 10, Company’s Director bought 7,000 for 0.88, making the whole transaction’s value amount to 6,167. This particular insider is now the holder of 18,350 in total.

Salarius Pharmaceuticals Inc. (SLRX) Earnings and Revenue Records

In the latest quarterly report released, which was put into the public domain on 6/29/2021, the organization reported -$0.07 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.06) by -$0.01. This company achieved a net margin of -140.49 while generating a return on equity of -44.91. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.

Salarius Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 76.60% and is forecasted to reach -0.34 in the upcoming year.

Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) Trading Performance Indicators

Let’s observe the current performance indicators for Salarius Pharmaceuticals Inc. (SLRX). The Stock has managed to achieve an average true range (ATR) of 0.05. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.67.

In the same vein, SLRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.36, a figure that is expected to reach -0.09 in the next quarter, and analysts are predicting that it will be -0.34 at the market close of one year from today.

Technical Analysis of Salarius Pharmaceuticals Inc. (SLRX)

If we take a close look at the recent performances of Salarius Pharmaceuticals Inc. (NASDAQ: SLRX), its last 5-days Average volume was 0.8 million that shows plunge from its year to date volume of 1.78 million. During the previous 9 days, stock’s Stochastic %D was recorded 28.82% While, its Average True Range was 0.0559.

>> 7 Top Picks for the Post-Pandemic Economy << 

Raw Stochastic average of Salarius Pharmaceuticals Inc. (SLRX) in the period of the previous 100 days is set at 16.56%, which indicates a major fall in contrast to 31.70% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 61.73% that was lower than 62.73% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

Sign up for Our Newsletter Now! Discover which stocks to trade!
100% Free. Stop Anytime. No Spam